» Articles » PMID: 38204442

Exploring Ideal Operative Time for Best Outcomes in Gastric Cancer Surgery: A Multi-institutional Study Based on KLASS-07 Database

Abstract

Objective: While a rushed operation can omit essential procedures, prolonged operative time results in higher morbidity. Nevertheless, the optimal operative time range remains uncertain. This study aimed to estimate the ideal operative time range and evaluate its applicability in laparoscopic cancer surgery.

Methods: A prospectively collected multicenter database of 397 patients who underwent laparoscopic distal gastrectomy were retrospectively reviewed. The ideal operative time range was statistically calculated by separately analyzing the operative time of uneventful surgeries. Finally, intraoperative and postoperative outcomes were compared among the shorter, ideal, and longer operative time groups.

Results: The statistically calculated ideal operative time was 135.4-165.4 min. The longer operative time (LOT) group had a lower rate of uneventful, perfect surgery than the ideal or shorter operative time (IOT/SOT) group (2.8% 8.8% and 2.2% 13.4%, all P<0.05). Longer operative time increased bleeding, postoperative morbidities, and delayed diet and discharge (all P<0.05). Particularly, an uneventful, perfect surgery could not be achieved when the operative time exceeded 240 min. Regardless of ideal time range, SOT group achieved the highest percentage of uneventful surgery (13.4%), which was possible by surgeon's ability to retrieve a higher number of lymph nodes and perform ≥150 gastrectomies annually.

Conclusions: Operative time longer than the ideal time range (especially ≥240 min) should be avoided. If the essential operative procedure were faithfully conducted without compromising oncological safety, an operative time shorter than the ideal range leaded to a better prognosis. Efforts to minimize operative time should be attempted with sufficient surgical experience.

Citing Articles

Evaluating the impact of a navigation system on the initial cases of robotic gastrectomy for gastric cancer.

Chung J, Lim D, Lee S, Hwang S J Robot Surg. 2025; 19(1):115.

PMID: 40080316 DOI: 10.1007/s11701-025-02262-z.


Short-Term Outcomes Analysis Comparing Open, Lap-Assisted, Totally Laparoscopic, and Robotic Total Gastrectomy for Gastric Cancer: A Network Meta-Analysis.

Manara M, Aiolfi A, Bonitta G, Schlanger D, Popa C, Lombardo F Cancers (Basel). 2024; 16(19).

PMID: 39410024 PMC: 11475391. DOI: 10.3390/cancers16193404.

References
1.
Lambert M . Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):251-255. PMC: 6142504. DOI: 10.1182/asheducation-2016.1.251. View

2.
Smith D, Schwarz R, Schwarz R . Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005; 23(28):7114-24. DOI: 10.1200/JCO.2005.14.621. View

3.
Wang X, Yao Y, Qian H, Li H, Zhu X . Longer Operating Time During Gastrectomy Has Adverse Effects on Short-Term Surgical Outcomes. J Surg Res. 2019; 243:151-159. DOI: 10.1016/j.jss.2019.05.021. View

4.
Evans C, Lim J, Gatzen C, Huang A . Factors influencing laparoscopic colorectal operative duration and its effect on clinical outcome. Surg Laparosc Endosc Percutan Tech. 2012; 22(5):437-42. DOI: 10.1097/SLE.0b013e31826020a3. View

5.
Lee C, Park J, Choi C, Lee H, Min J, Jee Y . A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol). BMC Cancer. 2019; 19(1):206. PMC: 6407283. DOI: 10.1186/s12885-019-5396-8. View